Merus Labs International Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 89   

Articles published

MSLI 1.42 -0.01 (-0.70%)
price chart
Short Interest of Merus Labs International Inc (USA) Increases by 26.5%
Merus Labs International Inc (USA) (NASDAQ:MSLI) reported a rise of 26.5% or 16,396 shares in its short interest. The short figure came in at 0.1% of the total floats.
Merus Labs International Inc. Completes $20 Million Bought Deal Financing
Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment dealers (the "Underwriters") co-led by Cormark ...
Related articles »  
Underperforming Companies for the Week: CYANOTECH CORP , Merus Labs ...
Merus Labs International Inc (USA) (NASDAQ:MSLI) has lost 9.68% during the past week and dropped 15.15% in the past 4 weeks.
Merus Labs International Inc. Files SEC Form SC 13G, Statement of Acquisition ...
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Merus Labs International Inc. (Form SC ...
Merus Labs International Inc. Announces Completion of $7 Million Financing ...
14, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce that, further to its news release dated July 4, 2014, the Company has today completed the financing acquisition transaction with Dacha ...
Related articles »  
Merus Labs International Inc. Announces Acquisition of Sintrom(R)
8, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce that one of its wholly owned subsidiaries has acquired from Novartis AG ("Novartis"), in certain European countries, the rights to ...
Merus Labs Acquire Sintrom from Novartis  Pharmaceutical Processing
Related articles »  
Merus Labs International Inc. Announces Aggregate $21 Million Financing ...
TORONTO, ONTARIO--(Marketwired - June 10, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today that the Company has entered into a private placement subscription agreement to ...
Related articles »  
EmergingGrowth.com looks at Merus Labs International Inc. After Better than ...
May 28, 2013 (ACCESSWIRE via COMTEX) -- Merus Labs International Inc. MSLI, +0.71% (MSL) is a specialty pharmaceutical company focused on the licensing and acquisition of recognized products that are under-promoted from larger pharmaceuticals.
Related articles »  
Merus Labs International Inc. Appoints Barry Fishman as Chief Executive Officer
TORONTO, ONTARIO, Dec 15, 2014 (Marketwired via COMTEX) -- The Board of Directors of Merus Labs International Inc. ("Merus" or the "Company") (MSL) MSLI, -3.47% is pleased to announce the appointment of Mr. Barry Fishman as CEO, effective today.
Related articles »  
Merus Labs International Inc. Announces Conversion of $10 Million Convertible ...
In aggregate, the Company will issue 6,677,918 common shares to convert the outstanding $10 million principal amount plus accrued but unpaid interest.
Related articles »